Primary Site >> Colorectal Cancer

Gene >> GNAS

  • 2005
  • 2006
  • 2007
  • 2010
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: GNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer.
PMID: 16033819
Ref: The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma.
PMID: 16467086
Ref: The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma.
PMID: 17186357
Ref: Distinct genetic alterations in colorectal cancer.
PMID: 20126641
Ref: Analysis of the frequency of GNAS codon 201 mutations in advanced colorectal cancer.
PMID: 20804925
Ref: Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.
PMID: 21445971
Ref: Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms.
PMID: 23403822
Ref: An integrative CGH, MSI and candidate genes methylation analysis of colorectal tumors.
PMID: 24475022
Ref: GNAS mutations identify a set of right-sided, RAS mutant, villous colon cancers.
PMID: 24498230
Ref: The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot study.
PMID: 24700299
Ref: Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin.
PMID: 24944587
Ref: GNAS1 mutation analysis in gastrointestinal tumors.
PMID: 25007176
Ref: Novel molecular insights from routine genotyping of colorectal carcinomas.
PMID: 25683705
Ref: Different treatment strategies and molecular features between right-sided and left-sided colon cancers.
PMID: 26074686
Ref: Next-Generation Sequencing of Matched Primary and Metastatic Rectal Adenocarcinomas Demonstrates Minimal Mutation Gain and Concordance to Colonic Adenocarcinomas.
PMID: 26536055
Ref: GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.
PMID: 27154293
Ref: Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing.
PMID: 27568332
Ref: Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
PMID: 27756406
Ref: Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report.
PMID: 27938333
Ref: Absence of GNAS mutation in colorectal carcinogenesis.
PMID: 26350188
Ref: Whole-exome sequencing identified mutational profiles of high-grade colon adenomas.
PMID: 28179590
Ref: Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis.
PMID: 28280620
Ref: Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.
PMID: 28749961
Ref: Acquired somatic TP53 or PIK3CA mutations are potential predictors of when polyps evolve into colorectal cancer.
PMID: 29069792
Ref: Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes.
PMID: 29180604
Ref: Genome wide DNA differential methylation regions in colorectal cancer patients in relation to blood related family members, obese and non-obese controls - a preliminary report.
PMID: 29876008
Ref: Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.
PMID: 30042065
Ref: Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
PMID: 30205948